Fluorescence-guided surgery (5-ALA)

What it is

Fluorescence-guided surgery uses a substance called 5-aminolevulinic acid (5-ALA), which the patient drinks before surgery and which causes high-grade glioma tissue to glow (fluoresce) under a special light. This helps the surgeon see the tumor and remove it more completely.

Understanding Fluorescence-guided surgery (5-ALA)

A key difficulty in glioma surgery is distinguishing tumor from normal brain, since infiltrating tumor can look similar to healthy tissue. 5-ALA helps solve this for high-grade gliomas: after the patient drinks it, the substance accumulates in tumor cells and, under a special blue light through the operating microscope, makes the tumor fluoresce a reddish-pink color while normal brain does not. This real-time visual distinction helps the surgeon identify and remove more of the tumor, improving the completeness of resection — which is associated with better outcomes in high-grade gliomas. 5-ALA is mainly useful for high-grade tumors (which fluoresce well); lower-grade tumors fluoresce less reliably. It is used alongside other tools and within the bounds of preserving function. Understanding fluorescence-guided surgery in gliomas clarifies how making tumor glow aids more complete removal.

Why it matters

Understanding fluorescence-guided surgery helps patients and families see how a substance that makes tumor glow helps the surgeon distinguish tumor from normal brain — improving the completeness of high-grade glioma removal.